Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth
Pre-publication versions of this article are available by contacting email@example.com.
|20 Jul 2017||Submitted||Original manuscript|
|23 Aug 2017||Author responded||Author comments - ke Zhang|
|Resubmission - Version 2|
|23 Aug 2017||Submitted||Manuscript version 2|
|6 Sep 2017||Reviewed||Reviewer Report - Qiang Li|
|18 Sep 2017||Reviewed||Reviewer Report - Ashok Dilly|
|12 Oct 2017||Reviewed||Reviewer Report - Zong Sheng Guo|
|10 Nov 2017||Author responded||Author comments - ke Zhang|
|Resubmission - Version 3|
|10 Nov 2017||Submitted||Manuscript version 3|
|4 Dec 2017||Reviewed||Reviewer Report - Zong Sheng Guo|
|4 Dec 2017||Reviewed||Reviewer Report - Qiang Li|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|8 Dec 2017||Editorially accepted|
|28 Dec 2017||Article published||10.1186/s12885-017-3903-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.